The blood glucose compliance time and insulin pump time in the optimized group were shorter than those in the general group, the insulin dosage was less than that in the general group, and the incidence of hypoglycemia was lower than that in the general group, with statistical significance (P < 0.05) (see Table 3). This evidence concerns the gene INS and Hypoglycemia.